93 5514 93 5514 (Carbamazepine extended-release 300 mg)

Pill imprint 93 5514 93 5514 has been identified as Carbamazepine extended-release 300 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; peripheral neuropathy (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 93 5514 93 5514 (Carbamazepine extended-release 300 mg)

Carbamazepine extended-release 300 mg 93 5514 93 5514
Carbamazepine extended-release
Imprint:
93 5514
93 5514
Strength:
300 mg
Color:
Green / Black
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-5514
Inactive Ingredients:
carnauba wax
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferrosoferric oxide
lactose monohydrate
polyethylene glycol 1450
propylene glycol
shellac
sodium lauryl sulfate
sorbitan monolaurate
titanium dioxide
povidone
sodium hydroxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web5)